Table 1: Comparison of DASH, pain, and difficulty to sleep between the prolotherapy group () and the control group () at baseline and at 12 weeks.

MeanPost-pre- improvement (%) value (Fisher’s exact test)
Baseline12 weeks

DASH score
Prolotherapy60.1443.8927.0%0.364
Control56.8646.6817.9%

Pain score
Prolotherapy3.291.8643.5%0.247
Control3.202.4025.0%

Difficulty to sleep score
Prolotherapy3.292.1534.6%0.027
Control2.202.60−18.2%

Level of significant set at .